- Location
narcolepsy
"-
According to a Research,One in Four People in The UK Suffer From Insomnia
Apr 8, 2014According to a research, one in four people in the UK suffer from insomnia, hypersomnia (excessive daytime sleepiness), snoring, sleepwalking, narcolepsy (falling asleep at inappropriate times), night terrors or apnoea. Makers of Vogue ...
Tags: Mattress, Furniture, Furnishing
-
Pandemrix Is Created in 2009 to Combat H1N1
Jan 21, 2014Pandemrix is an influenza vaccination, created in 2009 to combat H1N1, known as Swine Flu. Now, a team of Swedish clinicians testing the vaccine for links to immune-related or neurological diseases have linked Pandemrix to an increased risk ...
-
A New Study Links a Genetic Variation to Narcolepsy
Jan 7, 2014A new study links a genetic variation to narcolepsy, the medical condition that causes people to become excessively sleepy and even lapse into sleep involuntarily. The genetic variation is fairly common, while narcolepsy is rare. Among ...
Tags: genetic variation, narcolepsy, American Academy of Sleep Medicine
-
Most Cases of Narcolepsy Are Caused by a Misguided Immune System Attack
Dec 25, 2013A new study has uncovered evidence that most cases of narcolepsy are caused by a misguided immune system attack -- something that has been long suspected but unproven. Experts said the finding, reported Dec. 18 in Science Translational ...
Tags: narcolepsy, health, sleep disorder
-
Lupin Pharmaceuticals Gained Tentative FDA Approvals for Armodafinil Tablets
Aug 5, 2013Lupin Pharmaceuticals has gained tentative FDA approvals for Armodafinil tablets, 50mg, 100mg, 150mg, 200mg and 250mg strengths in addition to Doxycycline capsules, 40mg (30mg immediate-release and 10mg delayed-release). Armodafinil ...
-
Tris Pharma Has Launched Dextroamphetamine Sulfate Oral Solution
Jul 12, 2013Specialty pharmaceutical company Tris Pharma's generic pharmaceuticals business has launched Dextroamphetamine Sulfate Oral Solution to treat attention deficit disorder with hyperactivity (ADHD) and narcolepsy in the US. Available through ...
Tags: Tris Pharma, Medicine
-
Jazz Pharmaceuticals Has Received a US Patent for The Use of Xyrem Oral Solution
Dec 6, 2012Jazz Pharmaceuticals has received a US patent for the use of Xyrem (sodium oxybate) oral solution in narcolepsy treatment. The new patent entitled Microbiologically Sound and Stable Solutions of Gamma-Hydroxybutyrate Salt for the ...
Tags: pharmaceuticals, US patent, sodium oxybate, narcolepsy
-
Teva Pharmaceutical Industries Entered Into a Settlement Agreement
Dec 6, 2012Teva Pharmaceutical Industries has entered into a settlement agreement related to Nuvigil patent infringement litigation with Mylan. Under the agreement, Mylan is allowed to sell generic versions of 50mg, 150mg, and 250mg Nuvigil in June ...
Tags: Nuvigil, armodafinil tablets, Teva Pharmaceutical Industries, Mylan
-
Aerial BioPharma Won FDA Orphan Drug Designation for Its Narcolepsy Drug in Development
Dec 5, 2012Aerial BioPharma, a biopharmaceutical company, has won FDA orphan drug designation for its narcolepsy drug in development. The issuance of designation from the FDA follows the completion of a Phase IIa study in which N05 demonstrated ...
-
Mylan Pharmaceuticals Has Settled Provigil Litigation with Teva Pharmaceutical USA
Nov 29, 2012Mylan's subsidiary, Mylan Pharmaceuticals, has settled Provigil litigation with Teva Pharmaceutical USA. The settlement follows the Mylan litiagtion against the US Food and Drug Administration (FDA) regarding Mylan's abbreviated new drug ...
-
Jazz Pharmaceuticals Announced The Issuance of New Formulation Patent for Xyrem
Sep 12, 2012Jazz Pharmaceuticals, a specialty pharmaceutical company, has announced the issuance of new formulation patent for Xyrem (sodium oxybate) oral solution. Xyrem (sodium oxybate) oral solution is the FDA approved product for the ...
Tags: xyrem, cataplexy, patent, pharmaceutical product
-
Mylan Modafinil Tablets ANDA Wins Final Approval
Aug 13, 2012The US Food and Drug Administration (FDA) has granted final approval to Mylan Pharmaceuticals' abbreviated new drug application (ANDA) of Modafinil tablets USP,100 mg and 200 mg. Modafinil USP,100 mg and 200 mg tablets are generic ...
